Terms: = Kidney tumors AND PIM1, PIM, 5292, ENSG00000137193, P11309
9 results:
1. KLF2-induced circZKSCAN1 potentiates the tumorigenic properties of clear cell renal cell carcinoma by targeting the miR-1294/pim1 axis.
Li M; Zhang M; Chen M; Xiao J; Mu X; Peng J; Fan J
Cell Cycle; 2022 Jul; 21(13):1376-1390. PubMed ID: 35285410
[TBL] [Abstract] [Full Text] [Related]
2. The burden of polypharmacy and drug-drug interactions in older cancer patients treated with immunotherapy.
Guven DC; Kavgaci G; Aktepe OH; Yildirim HC; Sahin TK; Aksoy S; Erman M; Kilickap S; Yalcin S
J Oncol Pharm Pract; 2022 Jun; 28(4):785-793. PubMed ID: 33878976
[TBL] [Abstract] [Full Text] [Related]
3. [Application value of diffusion-weighted imaging signal pattern in the qualitative diagnosis of renal lesions with T(2)WI hypointensity].
Gou ZH; Yan F; Wang HY; Chen X; Guo AT; Ma L; Zhong Y; Ye HY
Zhonghua Yi Xue Za Zhi; 2019 Sep; 99(35):2756-2760. PubMed ID: 31550798
[No Abstract] [Full Text] [Related]
4. pim1 mediates epithelial-mesenchymal transition by targeting Smads and c-Myc in the nucleus and potentiates clear-cell renal-cell carcinoma oncogenesis.
Zhao B; Liu L; Mao J; Zhang Z; Wang Q; Li Q
Cell Death Dis; 2018 Feb; 9(3):307. PubMed ID: 29472550
[TBL] [Abstract] [Full Text] [Related]
5. High Throughput Kinomic Profiling of Human Clear Cell Renal Cell Carcinoma Identifies Kinase Activity Dependent Molecular Subtypes.
Anderson JC; Willey CD; Mehta A; Welaya K; Chen D; Duarte CW; Ghatalia P; Arafat W; Madan A; Sudarshan S; Naik G; Grizzle WE; Choueiri TK; Sonpavde G
PLoS One; 2015; 10(9):e0139267. PubMed ID: 26406598
[TBL] [Abstract] [Full Text] [Related]
6. Emerging strategies to overcome the resistance to current mTOR inhibitors in renal cell carcinoma.
Santoni M; Pantano F; Amantini C; Nabissi M; Conti A; Burattini L; Zoccoli A; Berardi R; Santoni G; Tonini G; Santini D; Cascinu S
Biochim Biophys Acta; 2014 Apr; 1845(2):221-31. PubMed ID: 24480319
[TBL] [Abstract] [Full Text] [Related]
7. Targeting pim kinase enhances the activity of sunitinib in renal cell carcinoma.
Mahalingam D; Espitia CM; Medina EC; Esquivel JA; Kelly KR; Bearss D; Choy G; Taverna P; Carew JS; Giles FJ; Nawrocki ST
Br J Cancer; 2011 Nov; 105(10):1563-73. PubMed ID: 22015557
[TBL] [Abstract] [Full Text] [Related]
8. Radiofrequency ablation of renal tumours: diagnostic accuracy of contrast-enhanced ultrasound for early detection of residual tumour.
Hoeffel C; Pousset M; Timsit MO; Elie C; Méjean A; Merran S; Tranquart F; Khairoune A; Joly D; Richard S; Hélénon O; Correas JM
Eur Radiol; 2010 Aug; 20(8):1812-21. PubMed ID: 20204642
[TBL] [Abstract] [Full Text] [Related]
9. Multiparametric flow cytometric analysis of signal transducer and activator of transcription 5 phosphorylation in immune cell subsets in vitro and following interleukin-2 immunotherapy.
Varker KA; Kondadasula SV; Go MR; Lesinski GB; Ghosh-Berkebile R; Lehman A; Monk JP; Olencki T; Kendra K; Carson WE
Clin Cancer Res; 2006 Oct; 12(19):5850-8. PubMed ID: 17020993
[TBL] [Abstract] [Full Text] [Related]
